Overall survival and updated results from a phase II study of sunitinib in Japanese patients with metastatic renal cell carcinoma.
暂无分享,去创建一个
T. Miki | H. Akaza | B. Houk | Y. Tomita | S. Naito | N. Shinohara | N. Nonomura | H. Fujimoto | Masayuki Takahashi | H. Uemura | T. Yuasa | M. Niwakawa | Y. Hasegawa | S. Mugiya | N. Agata